🇧🇷 Vanrafia in Brazil

Vanrafia (ATRASENTAN) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Vanrafia in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Brazil

Frequently asked questions

Is Vanrafia approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Vanrafia in Brazil?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.